Formulary Search

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

https://www.toxbase.org/

For agents not bound by activated charcoal e.g. iron, lithium, bodypackers

Prescribing in primary care on specialist recommendation 

Prescribing in primary care on specialist recommendation 

No local trust is a NHSE commissioned specialist cardiac centre

Prescribe on advice from specialist e.g. dietitian 

Prescribe on advice from specialist e.g. dietitian 

1st month supply from specialist team before request for primary care prescribing

Sayana Press

Patients may be trained to self-administer Sayana Press

Depo Provera

CSM advice: Depo-Provera should only be used when other methods of contraception are inappropriate. Benefits of using medroxyprogesterone acetate beyond 2 years should be evalated against risk.

Women with risk factors for osteoporosis should consider alternative methos of contraception.

1st month supply from specialist team before request for primary care prescribing

Off-label use. Hot flushes caused by long-term androgen suppression in men with prostate cancer

1st month supply from specialist team before request for primary care prescribing

See separate entry for use in menorrhagia and dysmenorrhoea.

Off-label use. On recommendation of palliative care team.

1st month supply from specialist team before request for primary care prescribing

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

Melatonin 2mg MR tablets are the recommended preferred 1st line product

Prescribe generically.  Circadin is NON-FORMULARY

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

If immediate onset of action is required or crushed to aid swallowing

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

Reserved ONLY if feeding tube in situ, or significant swallowing difficulties, and the use of the whole or crushed tablets are unsuitable

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

All formulations of melatonin for adults under 55 without neurodevelopmental disorders were agreed by APC as NON-FORMULARY

ONLY for patients OVER 55 YEARS (without neurodevelopmental disorders)

Maximum 13 weeks treatment

Not a cost effective option

Rapid eye movement  sleep behaviour disorder. (RBD)

On specialist recommendation

Melatonin 2mg MR tablets are the recommended preferred 1st line product

Prescribe generically.  Circadin is NON-FORMULARY

Rapid eye movement  sleep behaviour disorder. (RBD)

If immediate onset of action is required or crushed to aid swallowing

On specialist recommendation

Rapid eye movement  sleep behaviour disorder. (RBD)

Reserved ONLY if feeding tube in situ, or significant swallowing difficulties, and the use of the whole or crushed tablets are unsuitable

On specialist recommendation

Rapid eye movement  sleep behaviour disorder. (RBD)

For inducing sleep in people requiring an EEG or audiology testing

This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.

Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).

This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.

Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).

Not a preferred NSAID, limited place in therapy.

ASPH - restricted to rheumatology only.

This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.

Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).

On advice from specialist.  

NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g.  Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency  

Tablets and oral suspension are NOT bioequivalent. Do not confuse with mercaptamine (similar name).